Supplementary Table 1 from Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
Lorenzo Castagnoli,Manuela Iezzi, Gaia C. Ghedini, Valentina Ciravolo, Giulia Marzano,Alessia Lamolinara,Roberta Zappasodi,Patrizia Gasparini,Manuela Campiglio,Augusto Amici,Claudia Chiodoni,Arianna Palladini, Pier Luigi Lollini,Tiziana Triulzi,Sylvie Menard,Patrizia Nanni,Elda Tagliabue,Serenella M. Pupa crossref（2023）
摘要
HER2-positive BC patient pathobiological and clinical characteristics.
查看译文
AI 理解论文
溯源树
样例
